conference Tag
Events and Conferences

10:00 A.M. ET Presentation: Small Pharma’s progress in the development of N,N-dimethyltryptamine (“DMT”) assisted therapy for the treatment of Major Depressive Disorder  Presented by Peter Rands, CEO   Investor sign up: Registration link For more information about the conference, or to schedule a one-on-one meeting with Small Pharma’s management team, please contact KCSA Strategic Communications […]

Press Releases

Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small Pharma"), a neuropharmaceutical company focused on psychedelic-assisted therapies, today announced that Peter Rands, Chief Executive Officer, and Dr. Carol Routledge, Chief Medical and Scientific Officer, will present at Canaccord Genuity's 41st Annual Growth Conference on Tuesday, August 10, 2021.

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: